Clin2
NCT07702461Likely a fitRecruiting

Resistance training survey for people on weight loss meds

Obesity & OverweightDiabetes (DM)

Part of Brain & nervous system, Hormones & metabolism clinical trials.

This trial is an online survey to understand how people taking GLP-1 medications (like Ozempic or Wegovy) are doing with resistance training. If you're an adult on a stable dose of a GLP-1 med for weight or diabetes, your input can help shape better exercise advice.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
300 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 years old or older
  • You are currently taking a GLP-1 medication (like Ozempic, Wegovy, Mounjaro, etc.)
  • You have been on that medication for at least 3 months
  • Your dose has been the same for the past 4 to 8 weeks
  • You are using the medication for type 2 diabetes, weight loss, or weight management
  • You can read and answer a survey in English and are not currently or planning to be pregnant

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07787533Not yet recruiting
Digital strength training for midlife women on GLP-1 meds

This study looks at whether a guided strength-training app can help women in their 40s and 50s who are starting a GLP-1 medication (like Ozempic or Wegovy) build muscle and stay healthy. You'd follow a home-based workout plan for 12 weeks and attend a few in-person visits.

Baton Rouge, Louisiana
NCT07554417Not yet recruiting· Phase 4
Exercise and nutrition program for muscle preservation during GLP-1 treatment

This study tests whether a 12-week program of exercise and personalized nutrition counseling can help obese adults maintain muscle and bone while taking GLP-1 medications (drugs that help with weight loss). GLP-1 drugs can sometimes cause muscle loss, so this trial explores whether targeted exercise and nutrition can prevent that.

Houston, Texas
NCT07588984Not yet recruiting
Weight Loss Study: GLP-1 Medication and Behavioral Programs

This study looks at how GLP-1 medications (like Ozempic or Wegovy) combined with behavioral coaching through Noom affect weight loss and metabolic health over 12 months. You may qualify if you're interested in weight loss and willing to commit to a program for a year.

Princeton, New Jersey
NCT07457437Recruiting
Exercise and medication for weight loss in women

This study tests whether adding resistance exercise to a new weight-loss medication helps women preserve muscle while losing weight. It may be an option for women who want to protect their muscle mass during treatment.

Exeter, Devon
NCT07755085Not yet recruiting· Phase 4
GLP-1 medication for hip or knee replacement

This study tests whether a GLP-1 medication (like Ozempic) can help people with obesity who are having hip or knee replacement surgery. It aims to see if the medication improves recovery and outcomes.

Dartmouth, Nova Scotia
NCT07652333Recruiting
Strength training for muscle and mind on obesity medication

This study tests whether strength training can help adults taking new obesity medications (like Wegovy or Ozempic) maintain muscle and improve mental health. You would start the medication after your first study visit.

Pittsburgh, Pennsylvania

Hear when a new Obesity & Overweight trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.